Getinge Past Earnings Performance
Past criteria checks 2/6
Getinge has been growing earnings at an average annual rate of 1.8%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 3.7% per year. Getinge's return on equity is 5.6%, and it has net margins of 5%.
Key information
1.8%
Earnings growth rate
1.8%
EPS growth rate
Medical Equipment Industry Growth | 6.2% |
Revenue growth rate | 3.7% |
Return on equity | 5.6% |
Net Margin | 5.0% |
Next Earnings Update | 28 Jan 2025 |
Recent past performance updates
Recent updates
Getinge AB (publ)'s (STO:GETI B) Price In Tune With Earnings
Dec 05Getinge (STO:GETI B) Is Experiencing Growth In Returns On Capital
Oct 17Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Sep 19Pinning Down Getinge AB (publ)'s (STO:GETI B) P/E Is Difficult Right Now
Aug 23An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued
Aug 08Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 21We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)
Jun 27Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly
May 11Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates
Apr 25Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?
Apr 15The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts
Mar 30Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's
Mar 29The Return Trends At Getinge (STO:GETI B) Look Promising
Mar 21Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results
Feb 04There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price
Jan 20Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Jan 05Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price
Dec 20Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)
Dec 05Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet
Oct 06Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?
Sep 21Getinge's (STO:GETI B) Returns On Capital Are Heading Higher
Sep 03Is Getinge (STO:GETI B) A Risky Investment?
Jun 28Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?
Jun 15Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist
Jun 01At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?
May 05Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25
Apr 05Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement
Feb 28Is Getinge AB (publ) (STO:GETI B) Trading At A 42% Discount?
Feb 16Getinge (STO:GETI B) Is Paying Out A Larger Dividend Than Last Year
Feb 04Is Getinge (STO:GETI B) Using Too Much Debt?
Feb 03When Should You Buy Getinge AB (publ) (STO:GETI B)?
Jan 07Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 49%?
Nov 06Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet
Oct 07Revenue & Expenses Breakdown
How Getinge makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 33,591 | 1,691 | 10,342 | 1,330 |
30 Jun 24 | 33,328 | 2,584 | 10,235 | 1,292 |
31 Mar 24 | 32,199 | 2,285 | 9,956 | 1,207 |
31 Dec 23 | 31,827 | 2,412 | 9,681 | 1,192 |
30 Sep 23 | 30,423 | 2,251 | 9,260 | 1,258 |
30 Jun 23 | 29,756 | 2,154 | 9,004 | 1,232 |
31 Mar 23 | 29,251 | 2,543 | 8,672 | 1,228 |
31 Dec 22 | 28,292 | 2,491 | 8,386 | 1,185 |
30 Sep 22 | 27,781 | 2,707 | 8,240 | 1,008 |
30 Jun 22 | 27,146 | 2,665 | 8,060 | 952 |
31 Mar 22 | 27,062 | 2,860 | 8,005 | 903 |
31 Dec 21 | 27,049 | 2,970 | 7,927 | 851 |
30 Sep 21 | 27,900 | 3,292 | 8,090 | 891 |
30 Jun 21 | 29,571 | 3,916 | 8,221 | 899 |
31 Mar 21 | 29,955 | 3,612 | 8,390 | 1,035 |
31 Dec 20 | 29,819 | 3,239 | 8,783 | 1,033 |
30 Sep 20 | 29,478 | 3,050 | 8,830 | 952 |
30 Jun 20 | 27,738 | 1,878 | 8,958 | 920 |
31 Mar 20 | 27,044 | 1,487 | 9,017 | 757 |
31 Dec 19 | 26,559 | 1,222 | 8,854 | 762 |
30 Sep 19 | 25,951 | 1,030 | 8,644 | 744 |
30 Jun 19 | 25,398 | -632 | 8,628 | 724 |
31 Mar 19 | 24,852 | -654 | 8,455 | 718 |
31 Dec 18 | 24,172 | -967 | 8,292 | 691 |
30 Sep 18 | 23,653 | -727 | 8,157 | 676 |
30 Jun 18 | 22,914 | 847 | 7,867 | 670 |
31 Mar 18 | 22,552 | 676 | 7,747 | 642 |
31 Dec 17 | 22,495 | 1,096 | 7,740 | 594 |
30 Sep 17 | 17,061 | 596 | 5,858 | 504 |
30 Jun 17 | 19,046 | 390 | 6,360 | 496 |
31 Mar 17 | 20,604 | 701 | 6,783 | 500 |
31 Dec 16 | 22,170 | 698 | 7,201 | 538 |
30 Sep 16 | 29,650 | 1,203 | 9,512 | 628 |
30 Jun 16 | 29,646 | 1,462 | 9,561 | 624 |
31 Mar 16 | 29,900 | 1,410 | 9,777 | 607 |
31 Dec 15 | 30,235 | 1,390 | 9,905 | 598 |
30 Sep 15 | 29,303 | 1,429 | 9,722 | 574 |
30 Jun 15 | 28,603 | 1,622 | 9,471 | 574 |
31 Mar 15 | 27,749 | 1,850 | 9,069 | 591 |
31 Dec 14 | 26,669 | 1,433 | 8,596 | 597 |
30 Sep 14 | 25,843 | 1,672 | 8,403 | 620 |
30 Jun 14 | 25,468 | 1,718 | 8,180 | 620 |
31 Mar 14 | 25,157 | 1,776 | 8,040 | 612 |
31 Dec 13 | 25,287 | 2,285 | 7,962 | 619 |
Quality Earnings: GETI B has high quality earnings.
Growing Profit Margin: GETI B's current net profit margins (5%) are lower than last year (7.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GETI B's earnings have grown by 1.8% per year over the past 5 years.
Accelerating Growth: GETI B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: GETI B had negative earnings growth (-24.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (31%).
Return on Equity
High ROE: GETI B's Return on Equity (5.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 14:02 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Getinge AB (publ) is covered by 34 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sten Gustafsson | ABG Sundal Collier |
Kamla Singh | AlphaValue |
Scott Bardo | Berenberg |